FIA
DNA icon

Foundations Investment Advisors’s Ginkgo Bioworks DNA Stock Holding History

Foundations Investment Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-547
Closed -$7.31K – 823
2024
Q2 		$7.31K Sell
547
-12
-2% -$358 ﹤0.01% 751
2024
Q1 		$26K Sell
559
-308
-36% -$15.9K ﹤0.01% 697
2023
Q4 		$44.1K Sell
867
-99
-10% -$6.06K ﹤0.01% 658
2023
Q3 		$69.9K Sell
966
-2,011
-68% -$161K ﹤0.01% 628
2023
Q2 		$221K Sell
2,977
-24
-0.8% -$1.42K 0.01% 529
2023
Q1 		$160K Sell
3,001
-99
-3% -$6.27K 0.01% 490
2022
Q4 		$210K Sell
3,100
-334
-10% -$30.7K 0.01% 406
2022
Q3 		$429K Sell
3,434
-588
-15% -$70.1K 0.02% 274
2022
Q2 		$481K Sell
4,022
-99
-2% -$12.1K 0.02% 235
2022
Q1 		$633K Buy
4,121
+1,698
+70% +$330K 0.02% 166
2021
Q4 		$607K Buy
2,423
+428
+21% +$203K 0.02% 178
2021
Q3 		$956K Buy
+1,995
New +$971K 0.04% 116

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Foundations Investment Advisors's DNA Position: Q3 2024 in Review

Foundations Investment Advisors sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 547 shares — an estimated $7.31K sold.

Foundations Investment Advisors first reported a position in DNA in Q3 2021 and held it in 12 quarters. The position peaked at $956K in Q3 2021. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Foundations Investment Advisors reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Foundations Investment Advisors sold 547 Ginkgo Bioworks shares in Q3 2024, an estimated $7.31K.
  • Foundations Investment Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 12 quarters.
  • Foundations Investment Advisors's Ginkgo Bioworks position peaked at $956K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Foundations Investment Advisors's 13F filing for Q3 2024, filed 21 Oct 2024.